The Biden administration is taking new steps to protect the privacy of abortion-seekers after a federal judge halted the U.S. Food and Drug Administration’s (FDA) approval of the abortion drug mifepristone.
The new actions were announced on April 12, ahead of the third meeting of the interagency Task Force on Reproductive Health Access.